Moderna Scales Down Manufacturing
The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...
Daily7h
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case
Bengaluru: Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a ...
Hosted on MSN23h
ICMR confirms diarrhoeal pathogen in Guillain-Barre Syndrome case samples but cause of outbreak unclear
This is India's biggest outbreak of Guillain-Barre Syndrome. There are very few instances when high number of GBS cases are ...
The Lancet23h
COVID-19 Resource Centre
As of January 2024, changes have been made to our COVID-19 Resource Centre. A COVID-19 Collection is available where you can continue to explore and access The Lancet Group's COVID-19 research, ...